Eckhard R. Podack
14Patents
6h-index
9Co-inventors
55Inventor score
Filing activity: Jul 24, 2007 → Mar 10, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9017679B2 | Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins | Chemistry; Metallurgy | 25 | Active |
| US9499627B2 | Method for in vivo expansion of T regulatory cells | Chemistry; Metallurgy | 13 | Active |
| US9839670B2 | Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins | Chemistry; Metallurgy | 13 | Active |
| US8685384B2 | Recombinant cancer cell secreting modified heat shock protein-antigenic peptide complex | Emerging Cross-Sectional Technologies | 7 | Active |
| US8475785B2 | Allogeneic cancer cell-based immunotherapy | Human Necessities | 7 | Active |
| US9603925B2 | Compositions comprising TL1A-Ig fusion protein for the regulation of T regulatory cells, and methods for their use | Chemistry; Metallurgy | 6 | Active |
| US9238064B2 | Allogeneic cancer cell-based immunotherapy | Human Necessities | 5 | Active |
| US8968720B2 | Heat shock protein GP96 vaccination and methods of using same | Chemistry; Metallurgy | 5 | Active |
| US10279020B2 | Tumor vaccine | Human Necessities | 3 | Active |
| US11395846B2 | Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins | Chemistry; Metallurgy | 0 | Active |
| USRE48599E1 | Compositions comprising TLIA-Ig fusion protein for the regulation of T regulatory cells, and methods for their use | General | 0 | Active |
| US9468677B2 | Compositions comprising TL1A-Ig fusion protein for the regulation of T regulatory cells, and methods for their use | General | 0 | Revoked |
| US10934364B2 | Method for in vivo expansion of T regulatory cells | Chemistry; Metallurgy | 0 | Active |
| US10624950B2 | Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.